Research & development
Where tomorrow's medicines begin
A dedicated R&D centre staffed by formulation scientists, analytical chemists and clinical pharmacists.
Innovation pillars
Science with purpose
Novel Drug Delivery
Sustained-release, taste-masked and pediatric-friendly formulations.
API Optimisation
Polymorph screening and bioavailability enhancement.
Generic Equivalence
Rigorous bioequivalence studies for affordable alternatives.
Digital Lab
Data-driven formulation design backed by computational tools.
Development process
From concept to commercialisation
01
Ideation
Identify therapeutic gaps and market needs.
02
Formulation
Pre-formulation studies and prototype development.
03
Validation
Bioequivalence, stability and process validation.
04
Launch
Regulatory dossiers, scale-up and market introduction.
Infrastructure
Built for discovery
HPLC & UPLC Systems
Precision separation and quantification.
Stability Chambers
ICH-conforming long-term and accelerated conditions.
Dissolution Apparatus
USP types I–IV for varied dosage forms.
Microbiology Lab
Sterility, bioburden and endotoxin testing.
Pilot Plant
Bridging lab-scale to production-scale batches.
Document Management
Digital R&D records aligned with 21 CFR Part 11.